Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis

NCT07695701 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Amyloidosis
Amyloid Cardiomyopathy
Transthyretin Amyloidosis

Interventions

DRUG: Acoramidis (AG10) oral tablet

Sponsor

Eidos Therapeutics, a BridgeBio company